BioPharm Insight’s diverse team consistently provides an exceptional product and level of analysis to a readership comprising: top-tier investment banks, hedge funds and corporate subscribers in the healthcare sector. BioPharm Insight is a part of GlobalData, plc.
What you will do
Investigate potential market-moving situations in the biopharmaceutical space
Interview and build a comprehensive source book of key opinion leaders, physicians and industry experts
Write in-depth analysis pieces and break news with a target of 3-4 stories a week
Travel across the US or Europe (depending on location) to cover academic and industry conferences
Attend regular source meetings and events to build solid rapport with industry experts
What you will bring to the table
Scientific and/or journalism background as well as a demonstrable understanding of the pharmaceutical industry and R&D landscape
Experience covering oncology, cardiovascular diseases, metabolic diseases, rheumatic diseases, eye diseases or bone diseases
Previous experience on a daily or weekly healthcare-related publication
Excellent communication, networking, writing and interviewing skills
Ability to work in an interactive, time-sensitive and deadline-driven environment (often accommodating different global time zones)
Adaptable to working independently as well as with a team-oriented reporting approach.
To apply, please email US Editor – Surani Fernando – sfernando@biopharminsight.com
The Yale Program on Stakeholder Innovation and Management announced the appointment of Alan Murray, departing chief…
The Advocate is looking for a savvy reporter to cover the Baton Rouge business scene…
MLex, a LexisNexis company, is an independent news organization for breaking news and forward-looking analysis…
The Austin Business Journal seeks a staff writer to cover economic development in one of…
A Russian court on Saturday placed Sergei Mingazov, a journalist for the Russian edition of…
Justin Nielsen of Investor's Business Daily writes about the newspaper's 40th anniversary. Nielsen writes, "When the…